CIK 0001157075
- Non-accelerated filer
- Smaller reporting company
PharmaCyte Biotech, Inc.
Sign in to watch- Ticker
- PMCB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 621772151
- Phone
- +1 917-595-2850
- Business address
- 3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS, NV, 89169
- Former names
- NUVILEX, INC., EFOODSAFETY COM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-07 | Silverman Joshua CEO and President | Purchase | +40,000 | $0.83 | $33K | 416,250 |
| 2026-01-06 | Silverman Joshua CEO and President | Purchase | +30,000 | $0.79 | $24K | 376,250 |
| 2026-01-05 | Silverman Joshua CEO and President | Purchase | +30,000 | $0.78 | $23K | 346,250 |
| 2025-12-12 | Silverman Joshua CEO and President | Grant or award | +575,000 | 575,000 | ||
| 2025-12-12 | Silverman Joshua CEO and President | Shares withheld for taxes | −258,750 | $1.02 | $264K | 316,250 |
| 2023-11-20 | Silverman Joshua Interim CEO, Interim President | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 |
Page 1 of 1 · 6 trades